Cellebrite DI (CLBT) to Release Earnings on Thursday

Cellebrite DI (NASDAQ:CLBTGet Free Report) is projected to issue its quarterly earnings data before the market opens on Thursday, February 13th. Analysts expect the company to announce earnings of $0.10 per share and revenue of $107.26 million for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Cellebrite DI Stock Performance

NASDAQ:CLBT opened at $24.20 on Wednesday. Cellebrite DI has a 1 year low of $8.91 and a 1 year high of $26.30. The stock has a market cap of $4.98 billion, a P/E ratio of -15.61, a P/E/G ratio of 3.72 and a beta of 1.47. The stock has a 50-day simple moving average of $22.41 and a 200-day simple moving average of $18.97.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on CLBT shares. Craig Hallum increased their target price on shares of Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. JPMorgan Chase & Co. raised their target price on shares of Cellebrite DI from $24.00 to $28.00 and gave the stock an “overweight” rating in a research report on Tuesday. Finally, Needham & Company LLC increased their price target on shares of Cellebrite DI from $21.00 to $28.00 and gave the stock a “buy” rating in a research note on Wednesday, January 22nd. Eight equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, Cellebrite DI currently has an average rating of “Buy” and an average target price of $22.14.

View Our Latest Stock Report on CLBT

Cellebrite DI Company Profile

(Get Free Report)

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.

Featured Stories

Earnings History for Cellebrite DI (NASDAQ:CLBT)

Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.